Frankfurt/Tokyo, 7 December 2021 – DoKaSch Temperature Solutions continues to expand its business in Asia. With the dedicated subsidiary DoKaSch Temperature Solutions K.K. in Tokyo and a new service station at Narita International Airport, customers in Japan now have optimal access to the “Opticooler” – high-quality and reliable temperature-controlled packaging-solution by DoKaSch Temperature Solutions.
Japan is considered an important production and export center for pharmaceuticals in the Asian-Pacific region as well as worldwide. Especially in terms of biopharmaceuticals and vaccines, the demand for pharmaceutical cold chain capacity is increasing. Narita International Airport has one of the largest temperature-controlled storage facilities for airports in Japan, the Cargo Climate Control Terminal (CCC). The airport handles half of all pharmaceutical trade in Japan, making it one of the most important hubs for both import and export.
With its office in Tokyo and the new depot at Narita International Airport, DoKaSch Temperature Solutions is strengthening its network in the region and worldwide. In this way, the solution provider for temperature-controlled packaging contributes to a reliable cold chain for highly sensitive pharmaceutical products, especially during the pandemic. The capacities of RKN and RAP Opticooler at Narita Station can be increased at any time and immediately so that the required number of containers is available for each flight. Back in July, for example, DoKaSch Temperature Solutions K.K. provided Opticoolers for a large-scale and very important transport operation of vaccines.
"I see many opportunities for Opticooler in the important Japanese pharmaceutical market and beyond, because of its technical characteristics, exceptional reliability and availability. Because of our proximity and extensive network, we can serve customers quickly and reliably," says Kazuyoshi Kakizawa, head of DoKaSch Temperature Solutions K.K.. The experienced industry expert is responsible for the further development and expansion of DoKaSch's business in Japan and also for the company's operational activities in the East Asian island state.
Andreas Seitz, managing director of DoKaSch Temperature Solutions, adds: "Japan is a major production and export center for pharmaceuticals and biopharmaceuticals. Therefore, we decided to open a new DoKaSch office and station at Tokyo. It is directly related to our growth strategy in Asia and ideally complements our extensive global network. This allows us to further ensure that our Opticooler reaches our customers quickly and thus contribute to a smooth and reliable cold chain.”
